Alternative Medications for Anxiety After Discontinuation of Hydroxyzine
First-Line Pharmacologic Options
- The American College of Cardiology is not mentioned, however, the guideline recommends SSRIs, specifically escitalopram (10-20 mg/day) or sertraline (50-200 mg/day), as the first-line replacement for hydroxyzine in treating chronic anxiety disorders 1
- Escitalopram is the optimal initial choice due to its superior efficacy, favorable drug interaction profile, and lower discontinuation rates 2, 1
- Sertraline is an equally effective alternative with extensive safety data 2, 1
Expected Timeline
- Statistically significant improvement begins by week 2, clinically significant improvement by week 6, and maximal benefit by week 12 or later 1
- Full response may require 12+ weeks, and treatment should not be abandoned prematurely 1
Alternative First-Line: SNRIs
- Venlafaxine extended-release (75-225 mg/day) is effective across all anxiety disorders and requires blood pressure monitoring due to risk of sustained hypertension 1
- Duloxetine (60-120 mg/day) is particularly beneficial for patients with comorbid pain conditions 1
Combining Medication with Psychotherapy
- Adding cognitive behavioral therapy (CBT) to medication provides superior outcomes compared to either treatment alone 2, 1
- Individual CBT demonstrates large effect sizes for generalized anxiety disorder (Hedges g = 1.01) 1
Critical Monitoring Requirements
- Monitor closely for suicidal thinking and behavior, especially in the first months and following dose adjustments (pooled risk difference 0.7% vs placebo) 1
- Assess response using standardized anxiety rating scales such as HAM-A 2, 1
Medications to Avoid
- Benzodiazepines carry significant dependence risk and should not be used as routine replacements for hydroxyzine 3
- Tricyclic antidepressants should be avoided due to unfavorable risk-benefit profile, particularly cardiac toxicity 1
- Beta blockers (atenolol, propranolol) are deprecated based on negative evidence 1